Geographic location may help explain why Hispanics face disparities in kidney transplantation

In the United States, Hispanics with kidney failure are less likely than non-Hispanic whites to receive a kidney transplant largely due to their blood type and because of where they live, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The findings highlight the need to implement new deceased donor organ allocation policies that distribute organs over wider geographic areas to help reduce barriers to transplantation for Hispanics.

Hispanics represent the largest minority group in the United States and have an increased risk for developing compared with non-Hispanic whites. Prior studies have shown that Hispanics were less likely to be placed on the transplant waiting list, experienced longer waiting times, or were less likely to receive a kidney transplant compared with non-Hispanic whites. Cristina Maria Arce, MD (now at The Ohio State University Wexner Medical Center) and her former colleagues at Stanford University School of Medicine sought to study these issues further by analyzing data from the US Renal Data System, the national registry of individuals with kidney failure. The investigators identified 417,801 Caucasians who initiated dialysis from 1995 to 2007 and were followed through 2008.

Among the major findings:

  • Hispanics were just as likely as non-Hispanic whites to be put on the waitlist.
  • Once waitlisted, Hispanics were 21% less likely to receive a transplant from a deceased donor. But this disparity was largely explained by differences in patient blood type and regional variability of organ supply among organ procurement organizations across the country.

"The main barriers after placement on the waitlist include the tendency for Hispanics to reside in regions with organ procurement organizations characterized by longer median waiting times as well as the higher likelihood for Hispanics to have O, which further complicates organ allocations due to fewer ABO-compatible deceased donors," explained Dr. Arce. "To overcome the geographic disparities that Hispanics encounter in the path to transplantation, organ allocation policy revisions are needed to improve donor organ equity."

More information: The article, entitled "Differences in Access to Kidney Transplantation between Hispanic and non-Hispanic Whites by Geographic Location in the United States," will appear online on October 10, 2013, DOI: 10.2215/CJN01560213

add to favorites email to friend print save as pdf

Related Stories

Disparities exist in kidney transplant timing

Jan 31, 2013

African-Americans and individuals without private health insurance are less likely than others to receive a kidney transplant before requiring dialysis, according to a study appearing in an upcoming issue of the Clinical Jo ...

Racial inequalities exist for kids with kidney disease

Nov 10, 2011

Among children with kidney disease, certain races are less likely to get kidney transplants and are more likely to die than other races, according to two studies from Emory University that were presented during the American ...

Recommended for you

Doctor behind 'free radical' aging theory dies

16 hours ago

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.